Safety and feasibility of laparoscopic resection for giant hepatic hemangiomas: a retrospective cohort study

Giant hepatic hemangiomas can cause significant symptoms or complications, and laparoscopic resection remains technically demanding. This study assessed the safety and feasibility of laparoscopic resection for giant hemangiomas. A retrospective review was conducted of all patients undergoing laparoscopic resection (LR) for giant hepatic hemangiomas between July 2021 and April 2025 at a single tertiary center. Surgical indication was based on the presence of clinically relevant symptoms reasonably attributable to the hemangioma, after exclusion of alternative causes.In selected symptomatic patients, documented tumor growth (>1 cm/year) and unfavorable anatomical location, particularly proximity to major hepatic vessels, were considered supportive factors rather than independent indications for surgery.Demographic, operative, and postoperative data were analyzed. Outcomes were compared by tumor location (left vs right hepatic lobe) using the Mann–Whitney U test, with effect sizes expressed as Hodges–Lehmann median differences. Eighteen patients (83% female; median age 52 years) underwent laparoscopic resection with no conversions to open surgery. Median tumor size was 100 [IQR 90–140]. Median operative time was 227.5 [IQR 181.25–262.5], median blood loss 400 [IQR 325–575] and hospital stay 4.5 [IQR 4.0–5.0]. One minor postoperative complication classified as Clavien–Dindo grade II was observed. There were no major complications and no 90-day mortality. Operative time was significantly longer for right-lobe tumors (median 238 min [IQR 217–298]) vs left-lobe tumors (173 min [IQR 156–215]; Hodges–Lehmann difference 70 min, 95% CI 0–140; p = 0.049). Blood loss was higher in the right-lobe group (median 450 vs 350 ml), but this did not reach significance (p = 0.20). No recurrences were observed during follow-up (median 10 months). Laparoscopic resection of giant hepatic hemangiomas appeared to be feasible and safe in selected patients in this single-center experience. Right-lobe tumors were associated with longer operative times, reflecting greater technical complexity.

Authors

Institutions

Publication Details

Journal
BMC Surgery
Published
2026-02-14
DOI
https://doi.org/10.1186/s12893-026-03580-1
Primary Topic
Hepatocellular Carcinoma Treatment and Prognosis
Type
article
Field-Weighted Citation Impact
0.00
Controls
|||
ALL TIME
JAN
FEB
MAR
APR
MAY
JUN
JUL
AUG
SEP
OCT
article

Safety and feasibility of laparoscopic resection for giant hepatic hemangiomas: a retrospective cohort study

Tomasz Kozłowski, Aleksander Tarasik, Marian Domurat, Marcin Juchimiuk et al.
BMC Surgery
Hepatocellular Carcinoma Treatment and Prognosis
article

Safety and feasibility of laparoscopic resection for giant hepatic hemangiomas: a retrospective cohort study

Tomasz Kozłowski, Aleksander Tarasik, Marian Domurat, Marcin Juchimiuk, Kamil Safiejko, Mateusz Mucha, Wojciech Fiedorowicz, H. Puziuk, W. Dzieżyk, Jerzy Hapanowicz, Anna Parfieniuk-Kowerda
article en

Abstract

Giant hepatic hemangiomas can cause significant symptoms or complications, and laparoscopic resection remains technically demanding. This study assessed the safety and feasibility of laparoscopic resection for giant hemangiomas. A retrospective review was conducted of all patients undergoing laparoscopic resection (LR) for giant hepatic hemangiomas between July 2021 and April 2025 at a single tertiary center. Surgical indication was based on the presence of clinically relevant symptoms reasonably attributable to the hemangioma, after exclusion of alternative causes.In selected symptomatic patients, documented tumor growth (>1 cm/year) and unfavorable anatomical location, particularly proximity to major hepatic vessels, were considered supportive factors rather than independent indications for surgery.Demographic, operative, and postoperative data were analyzed. Outcomes were compared by tumor location (left vs right hepatic lobe) using the Mann–Whitney U test, with effect sizes expressed as Hodges–Lehmann median differences. Eighteen patients (83% female; median age 52 years) underwent laparoscopic resection with no conversions to open surgery. Median tumor size was 100 [IQR 90–140]. Median operative time was 227.5 [IQR 181.25–262.5], median blood loss 400 [IQR 325–575] and hospital stay 4.5 [IQR 4.0–5.0]. One minor postoperative complication classified as Clavien–Dindo grade II was observed. There were no major complications and no 90-day mortality. Operative time was significantly longer for right-lobe tumors (median 238 min [IQR 217–298]) vs left-lobe tumors (173 min [IQR 156–215]; Hodges–Lehmann difference 70 min, 95% CI 0–140; p = 0.049). Blood loss was higher in the right-lobe group (median 450 vs 350 ml), but this did not reach significance (p = 0.20). No recurrences were observed during follow-up (median 10 months). Laparoscopic resection of giant hepatic hemangiomas appeared to be feasible and safe in selected patients in this single-center experience. Right-lobe tumors were associated with longer operative times, reflecting greater technical complexity.

BMC SurgeryVol. 26(1)
Medical University of Białystok (PL)
Good health and well-being
Openalex Percentile: Top 55%
Hepatocellular Carcinoma Treatment and Prognosis
AI Navigator

Ask Laika to Summarize, Analyze, and Connect papers live on the map.

Summarize Papers & Methodologies

Extract key findings, datasets, and comparative methods across publications.

Benchmark Rankings & Visual Analytics

Rank top research institutions, authors, funders, topics, and journals by Field-Weighted Citation Impact (FWCI) and paper volume with instant charts.

Connect Distant Disciplines

Bridge topological clusters on the map to find hidden collaborative intersections.